- Home
- HONE vs RLAY Comparison
HONE vs RLAY Comparison
Compare HONE & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- RLAY
- Stock Information
- Founded
- HONE 1917
- RLAY 2015
- Country
- HONE United States
- RLAY United States
- Employees
- HONE N/A
- RLAY N/A
- Industry
- HONE Major Banks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HONE Finance
- RLAY Health Care
- Exchange
- HONE Nasdaq
- RLAY Nasdaq
- Market Cap
- HONE 547.7M
- RLAY 619.0M
- IPO Year
- HONE 2016
- RLAY 2020
- Fundamental
- Price
- HONE $13.20
- RLAY $4.09
- Analyst Decision
- HONE Buy
- RLAY Strong Buy
- Analyst Count
- HONE 3
- RLAY 13
- Target Price
- HONE $14.50
- RLAY $18.00
- AVG Volume (30 Days)
- HONE 198.2K
- RLAY 1.2M
- Earning Date
- HONE 10-23-2025
- RLAY 11-05-2025
- Dividend Yield
- HONE 2.76%
- RLAY N/A
- EPS Growth
- HONE 71.76
- RLAY N/A
- EPS
- HONE 0.65
- RLAY N/A
- Revenue
- HONE $164,819,000.00
- RLAY $8,355,000.00
- Revenue This Year
- HONE N/A
- RLAY $31.55
- Revenue Next Year
- HONE $14.24
- RLAY N/A
- P/E Ratio
- HONE $20.08
- RLAY N/A
- Revenue Growth
- HONE N/A
- RLAY N/A
- 52 Week Low
- HONE $8.89
- RLAY $1.78
- 52 Week High
- HONE $13.73
- RLAY $8.19
- Technical
- Relative Strength Index (RSI)
- HONE 66.28
- RLAY 60.92
- Support Level
- HONE $12.80
- RLAY $3.89
- Resistance Level
- HONE $13.18
- RLAY $4.34
- Average True Range (ATR)
- HONE 0.27
- RLAY 0.24
- MACD
- HONE 0.00
- RLAY 0.02
- Stochastic Oscillator
- HONE 74.09
- RLAY 69.94
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).